SuperworthDexCom shares outstanding DXCM
Diluted shares outstanding, averaged over each quarter, from 2012.
- Latest quarter, to Jun 30, 2026
- 390.1M
- On a year earlier
- −4.4%
- fewer shares
DexCom had 390.1M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 4.4% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 399M | −2% |
| FY2024 | 406.7M | −3% |
| FY2023 | 417.2M | −2% |
| FY2022 | 426M | +10% |
| FY2021 | 388.1M | −2% |
| FY2020 | 397.2M | +7% |
| FY2019 | 370.4M | +4% |
| FY2018 | 355.2M | +2% |
| FY2017 | 347.6M | +3% |
| FY2016 | 338M | +4% |
| FY2015 | 326.4M | +8% |
| FY2014 | 303.2M | +5% |
| FY2013 | 289.2M | +4% |
| FY2012 | 277.2M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 390.1M | −4% | |
| Q1 FY26 | 393.6M | −3% | |
| Q4 FY25 | 399M | −2% | |
| Q3 FY25 | 407.4M | −1% | |
| Q2 FY25 | 408.2M | −2% | |
| Q1 FY25 | 407.5M | −2% | |
| Q4 FY24 | 406.7M | −3% | |
| Q3 FY24 | 410.2M | −4% | |
| Q2 FY24 | 416.8M | −3% | |
| Q1 FY24 | 416.7M | −0% | |
| Q4 FY23 | 417.2M | −2% | |
| Q3 FY23 | 426.8M | +0% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on DexCom
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.